PD clinical trials The neuroprotective effects of GLP-1RAs, particularly exenatide, seem to be more promising in PD
Endoscopic therapies, including intragastric balloon therapy and endoscopic sleeve gastroplasty, generally produce more modest weight loss, often approximately 10%-13% at 6 months depending on procedure, patient selection, and follow-up intensity
These drugs bind to GLP 1 receptors on pancreatic, gastrointestinal and central nervous system cells to enhance glucose dependent insulin secretion
Thats where we celebrate your small victories like being consistent and working out five days this week, getting your steps in, lifting heavier, or meeting your water goals
*****Not available in all 50 states
Were just starting to tell the story